Jasper Therapeutics (JSPR) Insider Trading & Ownership $5.59 -0.01 (-0.18%) As of 03:10 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Jasper Therapeutics (NASDAQ:JSPR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$60.75K Get JSPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address JSPR Insider Buying and Selling by Quarter Jasper Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/12/2024Jeetinder Singh MahalCOOSell900$22.11$19,899.00 9/12/2024Jeetinder Singh MahalCOOSell900$21.23$19,107.00 6/12/2024Jeetinder Singh MahalCOOSell900$24.16$21,744.00 (Data available from 1/1/2013 forward) JSPR Insider Trading Activity - Frequently Asked Questions Who is on Jasper Therapeutics's Insider Roster? The list of insiders at Jasper Therapeutics includes Anna Louise French, Carlyle Group Inc., Holding Ltd Roche, Jeetinder Singh Mahal, Thomas G Wiggans, Velan Capital Investment Manag, and William Lis. Learn more on insiders at JSPR. What percentage of Jasper Therapeutics stock is owned by insiders? 4.60% of Jasper Therapeutics stock is owned by insiders. Learn more on JSPR's insider holdings. Which Jasper Therapeutics insiders have been buying company stock? The following insiders have purchased JSPR shares in the last 24 months: Thomas G Wiggans ($12,300.00), and Velan Capital Investment Manag ($4,532,500.00). How much insider buying is happening at Jasper Therapeutics? Insiders have purchased a total of 352,000 JSPR shares in the last 24 months for a total of $4,544,800.00 bought. Which Jasper Therapeutics insiders have been selling company stock? The following insiders have sold JSPR shares in the last 24 months: Jeetinder Singh Mahal ($99,486.00), and William Lis ($6,766.00). How much insider selling is happening at Jasper Therapeutics? Insiders have sold a total of 5,296 Jasper Therapeutics shares in the last 24 months for a total of $106,252.00 sold. Jasper Therapeutics Key ExecutivesMr. Ronald A. Martell (Age 62)President, CEO & Director Compensation: $892.45kMr. Herbert C. Cross (Age 52)CFO & Corporate Secretary Dr. Luca Di Noto Ph.D.Senior Vice President of Technical OperationsMr. David Ku M.D.Vice President of Corporate Development, Portfolio Strategy & ManagementMr. Matthew FordVice President of Human ResourcesDr. Wendy Pang M.D.Ph.D., Senior Vice President of Research & Translational MedicineDr. Edwin Jonathan Tucker M.D. (Age 52)Chief Medical Officer Ms. Patricia CarlosSenior Vice President of Regulatory Affairs & Quality More Insider Trading Tools from MarketBeat Related Companies PHAT Insider Transactions AURA Insider Transactions TRDA Insider Transactions TKNO Insider Transactions OLMA Insider Transactions CMPX Insider Transactions RCKT Insider Transactions HRTX Insider Transactions TERN Insider Transactions CDTX Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:JSPR) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
